p53 is a short-lived transcription factor that is frequently mutated in tumor cells. Work by several laboratories has already shown that the ubiquitin-proteasome pathway can largely account for p53 destruction, at least under specific experimental conditions. We report here that, in vitro, wild-type p53 is a sensitive substrate for milli-and microcalpain, which are abundant and ubiquitous cytoplasmic proteases. Degradation was dependent on p53 protein conformation. Mutants of p53 with altered tertiary structure displayed a wide range of susceptibility to calpains, some of them being largely resistant to degradation and others being more sensitive. This result suggests that the different mutants tested here adopt slightly different conformations to which calpains are sensitive but that cannot be discriminated by using monoclonal antibodies such as PAb1620 and PAb240. Inhibition of calpains by using the physiological inhibitor calpastatin leads to an elevation of p53 steady-state levels in cells expressing wild-type p53. Conversely, activation of calpains by calcium ionophore led to a reduction of p53 in mammalian cells, and the effect was blocked by cell-permeant calpain inhibitors. Cotransfection of p53-null cell lines with p53 and calpastatin expression vectors resulted in an increase in p53-dependent transcription activity. Taken together, these data support the idea that calpains may also contribute to the regulation of wild-type p53 protein levels in vivo.
The p53 protein is multifunctional and essential for maintenance of genomic integrity. It can function as a transcription factor (13, 46, 47, 53, 54, 76) , but it has also been proposed to play a role in DNA repair (1) , in homologous recombination (67) , and in the regulation of the translation of its own mRNA (51) . p53 can stimulate transcription of certain target genes in vitro and in vivo through the binding to specific DNA sequences termed PREs (p53-responsive elements) (3, 15, 18, 20, 29, 30, 56, 70) found in the promoter regions of genes involved in the control of the cell cycle, such as Waf1/Cip1 or the cyclin G gene (14, 16) , and in DNA repair (52) , such as GADD45 (28) . It can also inhibit transcription of a variety of viral and cellular genes devoid of PREs, such as the human genes encoding c-Fos, ␤-actin (21), proliferating cell nuclear antigen (68) , MDR1 (7) , and basic fibroblast growth factor (69) , probably by interacting with the TATA binding protein. Importantly, tumor-derived p53 mutants are no longer able to bind to PREs and to activate transcription (17, 30, 56, 70) . Of paramount importance for its function, the p53 protein can adopt different tertiary structures that can be monitored by using a panel of monoclonal antibodies. Importantly, wild-type p53 protein can both promote and suppress cell proliferation, and these opposing functions correlate to three alternative conformations of the protein (reviewed in references 46 and 47) . Moreover, altered function of a number of mutant p53s found in tumors correlates with partially destabilized tertiary structure (47) .
Posttranscriptional mechanisms play an important role in p53 gene regulation. In particular, p53 is one of the most unstable proteins found in higher eucaryotes. However, p53
can be dramatically stabilized in response to cues, such as DNA damage, that lead to half-life changes from minutes to hours (13, 23, 33, 34, 54, 61, 76) , and a decrease in degradation rate is responsible for the high steady-state level of a number of mutant p53s found in spontaneously occurring tumors. A major route for p53 destruction has recently been shown to involve the ubiquitin-proteasome pathway (9, 38) .
Calpains are a family of calcium-dependent intracellular proteases that can be divided into two major groups: the ubiquitous calpains, termed milli-and microcalpains according to the concentration of calcium necessary for revealing their activity in vitro, and tissue-specific calpains (for reviews, see references 11 and 59) . Ubiquitous calpains are stimulated by different proteins and phospholipids and are inhibited by a highly specific, high-molecular-weight protein inhibitor named calpastatin. Rather than peptide motifs, they recognize structural determinants, the nature of which remains to be characterized, and they usually cleave their substrates to only a limited extent. Ubiquitous calpains are usually considered exclusively cytoplasmic proteases. This observation is in concordance with the intracellular localization of most of their known or suspected substrates (also see Discussion). Using a series of in vitro degradation assays, we report here that wildtype p53 protein is a substrate for ubiquitous calpains and that degradation is dependent on p53 protein conformation. Modulation of calpain function in vivo, using selected cell lines, affected p53 steady-state levels and transcription functions. This finding indicates that activated calpains may also directly target p53 in living cells and that p53 breakdown may not occur exclusively by the ubiquitin-proteasome pathway. (40) was performed on a Milligen 9050 peptide synthesizer, using the fluorenylmethoxycarbonyl group as temporary amino protection. A23187, E64D, calpain inhibitor I, and calpain inhibitor II were from Sigma.
Cells, culture conditions, and preparation of cell extracts. Jurkat and SAOS cells are available from the American Type Cell Collection. H358a (20) and ts20 (10) cells are kind gifts from J. Roth and H. Ozer, respectively. Cells were grown in Dulbecco modified Eagle medium supplemented with 10% fetal calf serum at 37ЊC except ts20 cells, which were cultured at 32ЊC. For preparation of S100 cytosolic extracts, Jurkat cells were pelleted by centrifugation, washed twice in phosphate-buffered saline (PBS; 150 mM NaCl, 10 mM sodium phosphate [pH 7]), and then incubated for 5 min on ice in a hypotonic lysis buffer (20 mM HEPES [pH 7.5], 10 mM potassium acetate, 1.5 mM magnesium acetate; 2 ml for 5 ϫ 10 8 cells) without any detergent. Lysis was completed in a Dounce homogenizer and verified by microscopic examination. Nuclei were removed by lowspeed centrifugation (2,000 ϫ g for 15 min), and supernatants were centrifuged at 100,000 ϫ g for 1 h in a Beckman SW60 rotor. Cytoplasmic extracts (S100; 5 to 12 mg of protein per ml) were then aliquoted and frozen at Ϫ80ЊC until used (4, 6) . T3T3 and 3T3tx cells are described in reference 75. For assaying p53 in ts20 cells, nearly confluent cells were transferred to 39ЊC for 12 h, and A23187 was added at a concentration of 10 mg/ml in the presence or absence of either E64D, calpain inhibitor I, or calpain inhibitor II at a concentration of 50 M for the indicated period of times. Cytosolic extracts for immunoblotting analysis were prepared and processed as described elsewhere (48, 75) .
In vitro and in vivo expression plasmids. For translation of the human c-Fos protein and of hamster glyceraldehyde-3-phosphate dehydrogenase, we used plasmids FH2 and pSC1 (5), respectively. Most of the wild-type and mutant p53 expression plasmids are described in reference 58. Others were obtained by site-directed mutagenesis of a wild-type p53 cDNA by using standard methods. For cell transfection experiments, we used the following plasmids: (i) RE-CAT, in which the chloramphenicol acetyltransferase (CAT) gene is under the transcriptional control of the CON consensus sequence for p53 (20) placed upstream of a thymidine kinase minimal promoter (8); (ii) SVp53, in which a wild-type human p53 cDNA is placed under the transcriptional control of the simian virus 40 late promoter in the SV2oli vector (64); and (iii) CD136, in which the calpastatin cDNA (26) has been cloned in the BamHI and HindIII sites of pCDNAI-neo (InVitrogen).
In vitro transcription and translation. For transcription, plasmids were linearized with appropriate restriction enzymes and subsequently phenol extracted. Transcription using SP6, T3, and T7 RNA polymerases, depending on the expression vector, was performed as specified by the supplier (Promega), as was translation in the rabbit reticulocyte lysate in the presence of [ 35 S]methionine (Amersham). Alternatively, a TNT transcription-translation kit from Promega was used with circular plasmids. Translations were conducted at 37ЊC unless specified otherwise.
Degradation assays and protein analysis. Degradation experiments were carried out at 37ЊC in a final volume of 40 l. For degradation in cytoplasmic extracts, 1 l of the translation mixture and 35 l of pure or diluted S100 extract were mixed and prewarmed at 37ЊC. CaCl 2 (1 mM, final concentration) and, when necessary, protease inhibitors (see below) were then added in a volume of 4 l at a time taken as time zero. When one component was omitted, the volume was adjusted to 40 l with PBS. When degradation kinetics analyses were carried out in the presence of pure bovine millicalpain, the latter was usually added at a final concentration of 50 g/ml. For degradation kinetics experiments, aliquots of the reaction mix were sampled at various time points and the reaction was stopped by addition of electrophoresis loading buffer containing 1% sodium dodecyl sulfate. Samples were then electrophoresed through 15% gels as described by Laemmli (34) and electrotransferred onto nitrocellulose for autoradiography. When needed, protease inhibitors were used as follows: calpastatin peptide at 0.5 g/ml, leupeptin at 5 g/ml, aprotinin at 200 g/ml, and soybean trypsin inhibitor at 0.85 g/ml. Since significant variations of calpain activity are observed from one cell extract to another, susceptibilities to calpains of the different proteins tested here were always compared at 37ЊC in parallel experiments using the same S100 cytoplasmic extract batch. When accurate comparisons were sought, degradation kinetics experiments were conducted with diluted extracts to slow down degradation rates. The mouse (12) and human recombinant p53 proteins were produced in the baculovirus system and Escherichia coli, respectively. Production of human p53 in insect cells was conducted as specified by the manufacturer after cloning of a wild-type p53 cDNA into the pBlueBac III vector (InVitrogen). Extraction from Spodoptera frugiperda Sf9 cells nuclei was performed as described in reference 12, and immunopurification was performed as described in reference 37. One microgram of pure recombinant protein was digested in a final volume of 40 l of a PBS solution containing 1 mM CaCl 2 and various amounts (up to 50 g/ml) of pure bovine millicalpain.
Immunoprecipitations and immunoblotting analysis. Antibodies and conditions for immunoprecipitation of mutant and wild-type p53 have been described previously (41) . Immunoblotting experiments were conducted essentially as described elsewhere (48, 75) . Fifty micrograms of cell extract was used in the case of MCF7 and ts20 cells, and the immunodetection of p53 was performed with monoclonal antibody X77 (36) and an enhanced chemiluminescence kit from Dupont. Efficiency of protein transfer onto a nitrocellulose membrane was checked by using Ponceau red staining, and when necessary, immunoblots were probed with an anti-glyceraldehyde-3-phosphate dehydrogenase antibody for verifying that the same amount of protein was analyzed in each sample.
Cell transfection experiments. H358a and SAOS cells were seeded at a density of 2 ϫ 10 5 cells per well of six-well culture plates (Nunc). They were transfected 18 h later by using Lipofectin (Gibco/BRL) as specified by the supplier, and CAT assays were performed after a further 36 h of culture according to standard procedures (8) , using a Packard Instant Imager Instrument for analysis of thinlayer chromatography plates. Five hundred nanograms of the pRE-CAT reporter plasmid, 10 ng of the SVp53 p53 expression plasmid, when present, and various amounts of PM194 calpastatin expression vector were used per assay. p53 and calpastatin genes were placed under the transcriptional control of the simian virus 40 late promoter and of the cytomegalovirus promoter, respectively. Absence of SVp53 or reduced amounts of PM194 were consequently compensated for by addition of SV2oli and pcDNAI-neo, respectively, to keep constant the concentrations of both promoters in all transfection assays. MCF7 cells, seeded at a density of 10 6 cells per 60-mm-diameter culture dish, were transfected with various amounts of PM194, using Lipofectamine (Gibco/BRL) as specified by the supplier. The concentration of DNA was adjusted to 10 g per transfection by using pCDNAI-neo. Immunoblotting analysis was carried out 36 h later.
RESULTS
Wild-type human and mouse p53 proteins are substrates for calpains in vitro. The sensitivities of human and mouse p53 to calpains were tested by using a previously described in vitro assay (4, 5 ; also see Materials and Methods). Briefly, p53 was produced by translation in a rabbit reticulocyte lysate, which is devoid of any detectable calpain activity, and then mixed with an S100 human Jurkat or Daudi cell cytoplasmic extract, which contains the calpain activity, and finally degradation reactions were started by adding calcium for activating calpains. Alternatively, purified bovine millicalpain was directly added to the reticulocyte lysate in certain experiments. Translation reactions most often gave rise to a relatively complex pattern of peptides. The longest peptide corresponded to the full-length p53, and the shorter ones resulted from either internal initiation or premature termination. Importantly, the suppressor conformation of the in vitro-translated proteins was confirmed before each degradation experiment by immunoprecipitation using monoclonal antibodies PAb240 and PAb1620 as previously described (41) .
Initial degradation experiments were carried out in the presence of 200 M calcium, which allows the activation of both micro-and millicalpains, since the former requires 2 to 75 M calcium for half-maximum activity and the latter requires 200 to 800 M (11). Similar results were obtained whether the protein was of human or murine origin. p53 was stable in the reticulocyte lysate for at least 2 h. When both calcium and the S100 cytoplasmic extract were added, p53 decayed rapidly ( Fig.  1) . Proteolysis was reproducibly two-to fivefold slower than that of the c-Fos proto-oncoprotein, which was processed in parallel and which is one of the most susceptible substrates identified for calpains (4, 5) (Fig. 1) . Degradation was specific, since no decay of hamster glyceraldehyde-3-phosphate dehydrogenase and mouse dihydrofolate reductase was detected in experiments conducted in parallel ( Fig. 1 , lower panels). Degradation was limited, since a number of proteolytic products accumulated in the assay, in keeping with the notion that calpains usually degrade their substrates to a limited extent (11) . The proteolytic product pattern was very simple in the case of the mouse protein, with the accumulation of two major bands of 33 and 41 kDa (also see below), and was complex in the case of human p53. In the latter case, the complexity is partly due to the complex pattern of translation products in the reticulocyte lysate that complicates the analysis. Typical degradation kinetics are presented in Fig. 1 .
As a next step, we verified that calpains, but not another, unidentified calcium-dependent protease(s), were responsible for the cleavage of p53. Calpain activity (with no discrimination between micro-and millicalpains) can be identified by using a series of protease inhibitors (for a review, see reference 73). On one hand, calpains are inhibited by calcium chelators such as EGTA, by cysteine protease inhibitors such as leupeptin, and most specifically by the highly specific endogenous inhibitor calpastatin or by a 27-mer synthetic peptide derived from it (called hereafter calpastatin peptide) (39) . Calpains are not inhibited by soybean trypsin inhibitor and the serine protease inhibitor aprotinin. Calcium-dependent degradation of p53 was insensitive to soybean trypsin inhibitor and aprotinin but totally inhibited by EGTA, leupeptin, and the calpastatin peptide ( Fig. 2A) , thus demonstrating the involvement of calpains. We next showed that both micro-and millicalpain can induce p53 cleavage in vitro. First, cleavage of both mouse and human p53 was obtained in the presence of 50 M calcium only (that is, a condition under which millicalpain is not activated) (Fig. 2B ). The degree of degradation of p53 was, however, less at 50 M than at higher calcium concentrations. This is most likely due to exhaustion of microcalpain activity under the experimental conditions used and not to differences in cleavage specificity between micro-and millicalpain, since a p53 protein added after 30 min of incubation was not degraded upon further incubation (not shown). Second, addition of purified bovine millicalpain directly to the reticulocyte lysate in the presence of 1 mM calcium caused rapid p53 decay (Fig.  2C) . Finally, we demonstrated that p53 is itself a substrate for calpains in S100 cytoplasmic extracts rather than for another protease activated (directly or indirectly) through proteolysis by calpains. To this end, we used the following two-step degradation assay as follows: (i) p53 was first incubated for 30 min in Jurkat S100 extract in the presence of calcium, i.e., a time sufficient for activation of a second possible protease and degradation of the input p53 (Fig. 3A , lane b); (ii) fresh p53 was then added to the reaction, and incubation was continued for another 30 min under conditions that are permissive (i.e., in the presence of calcium) or nonpermissive (i.e., in the presence of EGTA or of the calpastatin peptide) for calpains. In the presence of calcium alone, p53 decayed rapidly, indicating that the p53-specific protease is not exhausted after 30 min of incubation (Fig. 3A , lane c). In contrast, calcium chelation (Fig. 3A, lane d) or, more significantly, the calpastatin peptide (Fig. 3 , lane e) blocked degradation, thus implicating calpains as responsible for p53 proteolysis in the assay.
The degradation of pure recombinant wild-type mouse and human p53 by purified bovine millicalpain in vitro in the presence of calcium provided conclusive evidence that p53 is a substrate for calpains. At a high calpain concentration, a 33-kDa fragment prominently accumulated in the case of the mouse p53, in agreement with the size of the shorter proteolytic product generated in S100 cytoplasmic extracts. A more complex pattern of bands was again observed in the case of the human protein (Fig. 3B) . It is of note that this experiment indicates that there is no absolute dependence on any cytoplasmic cofactor for p53 degradation by calpains.
In vitro-translated mouse p53 usually yields a simpler proteolytic product pattern than the human protein, as only two major peptides (peptide 1 [41 kDa] and peptide 2 [33 kDa]) are observed, thus making it a better candidate for the mapping of calpain cleavage sites. The peptide fragments were mapped by immunoprecipitation using monoclonal antibodies PAb248 (amino terminus), PAb421 (carboxyl terminus), and PAb246 (central core domain). Both peptides were immunoreactive for PAb246, but none of them was positive for PAb248 and only peptide 1 reacted with PAb421 (Fig. 3C ). This result indicates that calpains cleave on both sides of the p53 central core domain responsible for DNA binding (2, 55) . Reactivity with PAb246 indicates that the central core domain (peptide 2) retained conformational integrity. Peptide 2 appeared later than peptide 1 in degradation kinetics experiments ( Fig. 1 and  2 ), suggesting that the N and C termini are sequentially removed, with the N terminus being cleaved first.
p53 sensitivity to calpains is determined primarily by the tertiary structure and not by the oligomerization state. Monomers of p53 assemble into dimers and higher-molecular-weight oligomers with high affinity via the oligomerization domain residing at the C terminus of the protein. Human and mouse p53 expression vectors linearized at unique SspI and StuI restriction enzyme sites, respectively, were used to produce monomeric proteins truncated within the oligomerization domains (49), which were tested for their sensitivity to calpains (Fig. 4) . Truncated monomeric mouse and human p53 displayed a sensitivity close to that of full-length proteins, thus showing that an intact quaternary structure is not a prerequisite for cleavage.
As calpains recognize structural, rather than sequence, motifs, it was important to test the possibility that the various conformations of p53 are unequally sensitive to calpains. First, we showed that heat-denatured (65ЊC for 5 min) human and murine p53 are resistant to cleavage by calpains (Fig. 5A) . The possibility of insolubilization upon heating that would have rendered p53 resistant to calpains was ruled out since under the same conditions, p53 retained its sensitivity to trypsin (not shown). We then used p53 mutants known to be temperature sensitive for conformation to examine whether conformation affects susceptibility to calpain degradation. Wild-type and mutant conformations of p53 are recognized by monoclonal antibodies PAb1620 and PAb240, respectively. The mouse A135V (45) and human A138V (73) p53 mutants were less susceptible to calpains in the PAb1620 0 /PAb240 ϩ conformation than in the PAb1620 ϩ /PAb240 0 conformation ( Fig. 5B and C) . The two mutant proteins, however, behave slightly differently in degradation kinetic experiments. The mouse A135V mutant can quantitatively adopt the PAb1620 cause no detectable amount of protein translated at 39ЊC undergoes any conformation change when shifted to 37ЊC, at least for the duration of the experiment (not shown), and the conformation change occurs much more slowly than degradation by calpains when proteins translated at 27ЊC are shifted to 37ЊC. Experiments presented in Fig. 5C show that A135V translated at 27ЊC displays a sensitivity to calpains in S100 Jurkat cell extract comparable to that of the wild-type mouse protein whereas it is a poor substrate for calpains in its PAb1620 0 /PAb240 ϩ conformation. Similarly, A138V proved to be a poor substrate for calpains when translated at 39ЊC and a better one when translated at 27ЊC (Fig. 5B) . Its apparent degradation rate, however, turned out to be lower than that of the wild-type protein when translated at 27ЊC, with 50% degradation occurring after 5 min of reaction, compared to less than 1 min for wild-type p53. This observation is consistent with (i) the mixed phenotype of A138V at 27ЊC and (ii) the idea that the PAb1620 0 /PAb240 ϩ conformation of this protein is a poor substrate for calpains. Comparable observations were made when pure bovine millicalpain was added to in vitro translation mixes (not shown).
We next determined whether the p53 protein synthesized in vivo was also sensitive to calpains. For this purpose, we used the mouse T3T3 and 3T3tx cell lines, which are derived from BALB/c fibroblasts. Both lines express high amounts of p53 detectable by immunoblotting (48, 75) . T3T3 p53 protein harbors two point mutations and adopts a mutant conformation (PAb240 ϩ ) when produced in vitro in reticulocyte lysate. Surprisingly, it adopts a wild-type conformation (PAb1620 ϩ ) when expressed in vivo. In this case, however, it is predominantly monomeric, with a small proportion being associated with a low-molecular-weight protein (48) . 3T3tx p53 also carries two point mutations but is quantitatively found in high-molecularweight complexes in vivo and displays a mutant conformation (PAb240 ϩ ) (48) . Cytosolic extracts from both cell lines were prepared, and the sensitivities to calpains of both p53 proteins were tested in parallel experiments (Fig. 6) . Addition of calcium triggers the cleavage of T3T3 p53 and the subsequent appearance of two peptides with molecular weights close to those of peptides 1 and 2 (see above). Consistent with a role for calpains, the cleavage is inhibited in the presence of calpastatin or of EGTA. Notably, only half of the protein is broken down, even when exogenous calpain is added to the reaction mixture. The reason for this is not clear, but one possible explanation is that interaction with cell proteins controlling the tertiary and/or the quaternary structure of T3T3 p53 may protect p53 from attack by calpains. 3T3tx p53 was resistant to proteolysis in the presence of calcium even when purified bovine millicalpain was added to the extract. This finding rules out the possibility that the absence of cleavage was due to rate-limiting amounts of calpains in this cell context and supports the notion that 3T3tx p53 protein is resistant to calpains because of its mutant conformation. Natural mutant p53 proteins display different sensitivities to cleavage by calpains. We next compared the susceptibility to calpains of wild-type p53 with those of 10 human p53 mutant proteins found in various types of natural tumors (R175H, M237I, M246V, R248W, R273C, R273H, R273P, T256A, V272M, and D281Y) and of three mouse mutants (C138H, C138P, and H176C [58] ). All of the mutants exhibit size fractionation profiles similar to that of wild-type human p53, with peaks equivalent to monomers, dimers, and high-molecularweight structures, in line with the idea that mutant proteins
FIG. 5. Influence of p53 tertiary structure upon proteolysis by calpains. (A)
Degradation of heat-denatured p53. Human and mouse p53 were produced in the reticulocyte lysate and heated at 65ЊC for 5 min. The sensitivities to calpains of nondenatured (ND) and heat-denatured (HD) proteins were subsequently compared in a Jurkat cell S100 extract in the presence of 200 M CaCl 2 as described for Fig. 1 . EGTA was added at a final concentration of 1 mM to block degradation. (B) Susceptibility to calpains of the human A138V p53 mutant translated at 27 and 39ЊC. A138V was produced in the reticulocyte lysate either at 27ЊC (A138V-27) or 39ЊC (A138V-39), and its conformation was tested by immunoprecipitation using antibodies PAb1620 and PAb240 (see text). Degradation kinetic experiments were conducted at 37ЊC in a Jurkat cell S100 extract (1 mg/ml) in the presence of 200 M CaCl 2 in parallel with that of the wild-type (wt) human p53. EGTA was added at a final concentration of 1 mM as a negative control in degradation experiments. (C) Susceptibility to calpains of the mouse A135V p53 mutant translated at 27 and 39ЊC. The same experiments as in panel B were conducted with the mouse A135V mutant.
FIG. 6. p53 degradation by calpains in T3T3 and 3T3tx cell cytosolic extracts. Cytosolic extracts were prepared and processed as indicated in Materials and Methods. Degradation experiments were carried out at 37ЊC for 60 min. Calcium, EGTA, bovine millicalpain, and the calpastatin peptide were added at concentrations of 1 mM, 2 mM, 50 g/ml, and 0.4 mg/ml, respectively. Immunodetection of p53 was obtained by using a combination of monoclonal antibodies as indicated in Materials and Methods.
retain the oligomerization properties of the wild-type protein (57) . They are all reactive with antibody PAb240 at 37ЊC (see Discussion) but not with PAb1620. The sole exception was R248W, which is negative for PAb240 and weakly positive for PAb1620 (57) . Three classes of mutants could easily be distinguished (Table 1) : (i) mutants that are as sensitive as the wild-type p53, including the human M246V, T256A, V272M, and D281Y and the mouse C138H, C138P, and H176C proteins; (ii) mutants that are more sensitive than wild-type p53, including human R248W, R273C, and R273H proteins; and (iii) mutants with reduced sensitivity to calpains, which include R175H, M237I, and R273P. Typical degradation experiments conducted with Jurkat cell cytosolic extract are presented in Fig. 7 . Similar observations were also made when bovine millicalpain was directly added to wild-type and mutant p53-containing reticulocyte lysate (not shown). In the case of mutants showing reduced sensitivity, significant amounts of protein were still detectable after 15 min for R175H and after 1 h for M237I and R273P, while wild-type protein and calpain-sensitive mutants were quantitatively degraded within the 1-min range under the experimental conditions used (Fig. 7B) . It is of note that R175H, M237I, and R273P were significantly less resistant than the mouse A135V or the human A138V mutant translated at 39ЊC (Fig. 5) . For analyzing hypersensitive mutants, milder proteolysis conditions were chosen. Whereas 15 to 30 min is necessary for degrading half of the wild-type p53 under the conditions used, R248W, R273H, and R273C decayed quantitatively in less than 2 to 5 min (Fig. 7A) . It is noteworthy that the pattern of proteolytic products indicates a more extensive proteolysis of the mutants.
Increased p53-dependent transcription in SAOS and H358a cells transfected with a calpastatin expression vector. Direct assessment of the effect of calpains on p53 turnover in vivo is difficult for several reasons. First, calpains are reputed to be largely, if not exclusively, localized in the cytoplasm. Thus, if p53 is a substrate for calpains in vivo, it should be vulnerable for a short period of time after synthesis since, in principle, it should be protected as soon as it enters the nucleus (also see Discussion). Second, the regulation of calpain activity in vivo is unclear, and no means for exclusive activation of these proteases has ever been described. Third, no cell-permeant protease inhibitor that is strictly specific for calpains is currently available (11, 59, 73) . To test the possible involvement of calpains in the regulation of p53 abundance, we initially used an indirect assay based on monitoring p53-dependent transcription in transient transfection experiments. To this aim, the p53-null SAOS (40) and H358a (19) cell lines were transfected with combinations of the following plasmids: (i) a wild-type human p53 expression vector (SVp53) in a limited amount to allow further p53-dependent transcription activity upon p53 stabilization; (ii) a reporter plasmid (RE-CAT) in which transcription of the bacterial CAT gene is under the control of the CON consensus DNA binding motif for p53 (20) ; and (iii) an expression vector for calpastatin (PM194), the physiological inhibitor of calpains in vivo. No stimulation of the reporter plasmid transcription was observed in the absence of p53 with any amount of calpastatin-expression plasmid. However, cotransfection of increasing amounts of the calpastatin expression vector, together with a constant amount of the p53 expression plasmid, led to a dose-dependent stimulation of p53 transcription activity. This level increased to five-and sevenfold in the cases of H358a and SAOS cells, respectively, under the experimental conditions tested (Fig. 8) .
Increased p53 steady-state level in MCF7 cells transfected with a calpastatin expression vector. Since the previous experiments could be interpreted as demonstrating an indirect effect of calpains on the control of p53 transcription activity, it was important to show that modulation of calpain activity could lead to variations in p53 steady-state level. We thus tested the possibility that calpain inhibition could lead to higher accumulation of p53 in living cells. To this aim, MCF7 human breast a Sensitivities to calpains of the human and mouse wild-type proteins were compared to those of p53 mutants in parallel experiments conducted as described for Fig. 7 . The flexibility of most mutants has been reported elsewhere (57) (also see text). VS, S, and PS correspond to very sensitive, as sensitive as wild-type p53, and poorly sensitive. See the text and legends to Fig. 5 and 7 for more information.
FIG. 7. Sensitivity to calpains of various human p53 mutants. (A)
Analysis of mutants with increased sensitivity to calpains. Wild-type and mutant p53 were processed in parallel degradation kinetic experiments as described for Fig. 1 in the presence of 1 mM CaCl 2 . Since overall calpain activities vary from one cell extract to another, a Jurkat cell cytoplasmic extract with low calpain activity was used to show more clearly the differences between wild-type (wt) p53 and the mutants tested in this series of experiment. (B) Analysis of mutants with reduced sensitivity to calpains. Experiments were conducted as for panel A but with a Jurkat cell extract displaying a high calpain activity. calpastat., calpastatin.
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on June 30, 2017 by guest http://mcb.asm.org/ tumor cells, in which wild-type p53 accumulates to easily detectable levels, were transfected with increasing amounts of the PM194 calpastatin expression vector. The anti-p53 monoclonal antibody X77 (36) was used since it also recognizes an unknown protein of 30 kDa which did not vary and was thus useful as an internal reference (u.p. [for unknown protein] in Fig. 9) . The results showed a dose-dependent accumulation of p53 ( Fig. 9A ) with a maximum threefold stimulation under the conditions used.
Reduced accumulation of p53 in ts20 cells treated with calcium ionophore. ts20 cells are thermosensitive for the E1 ubiquitin-activating enzyme of the ubiquitin cycle (9) . At the nonpermissive temperature (39ЊC), p53 continuously accumulates over a period of at least 24 h (not shown), because its degradation is essentially ubiquitin dependent in these cells cultured under standard conditions (9) . To test the possibility that calpain activation could lead to a reduction in p53 abundance, ts20 cells cultured at 32ЊC were transferred at 39ЊC for 12 h, i.e., a time at which ongoing p53 synthesis provides a situation for proteolytic attack by calpains in the cytoplasm. The calcium ionophore A23187, which activates calpains in vivo, was then added, and p53 abundance was subsequently monitored as a function of time by immunoblotting using monoclonal antibody X77. Whereas p53 abundance increased up to 300 to 400% over a 4-h period in the control experiment, only a 50% increase was detected in the presence of calcium ionophore (Fig. 9B) .
In addition to activating calpains, calcium ionophore induces a number of other intracellular events that might account for the control of p53 abundance. We therefore repeated the temperature shift experiment, with and without ionophore, this time adding separately protease inhibitors known to penetrate living cells. The inhibitors were E64D, calpain inhibitor
. None is strictly selective for calpains. E64D and calpain inhibitor I also inhibit cysteine proteases such as lysosomal cathepsins, but not the proteasome, whereas calpain inhibitor II also inhibits lysosomal proteases and the proteasome. However, all three inhibit calpains, and it follows that a common effect is likely to involve calpain inhibition. In the presence of ionophore alone, p53 failed to accumulate following a temperature shift to 39ЊC (Fig. 9C) . This result is consistent with those of the previous experiment (Fig. 9B) . However, when cells were treated with ionophore plus protease inhibitors, cellular p53 protein increased to levels equal to or greater than those induced in the absence of ionophore (Fig. 9C) . Since all three inhibitors had similar effects, Twelve hours after transfer at 39ЊC (time zero), ts20 cells were cultured in the presence or absence of A21187 for various periods of time, and cell extracts were analyzed by immunoblotting using X77. (C) Accumulation of p53 in ts20 cells cultured at 39ЊC in the presence of calcium ionophore and calpain inhibitors (calp. inh.). ts20 cells were processed as for panel B except that calpain inhibitors were added as indicated. Relative amounts of p53 were deduced from densitometer analysis of the autoradiograms, using u.p. as an internal invariant reference, and are indicated. Slight differences in the p53/u.p. signal ratio are visible at times zero. They reflect variations in the accumulation of p53 after 12 h of culture at 39ЊC. the increased level of p53 likely resulted from calpain inhibition.
DISCUSSION
p53 conformation and cleavage by calpains. Our results demonstrate that both human and mouse p53 can be cleaved by milli-and microcalpains in vitro, and cell studies strongly suggest that p53 may also be a substrate for calpains in vivo. While this report was in revision, very similar results were reported by Kubbutat and Vousden for the human protein (33) . Cleavage is independent of quaternary structure. However, p53 protein conformation appears crucial for calpain recognition and/or cleavage. Consistent with the notion that calpains do not fully degrade their substrates (11, 59) , discrete and stable proteolytic products accumulated in the degradation assays used here for both human and mouse p53. Speciesspecific patterns were, however, observed. The motifs recognized and cleaved by calpains in their substrate proteins have not yet been clearly identified. They are likely to be of a conformational nature with no strict dependence on specific amino acids at the level of scissile bonds, although amino acid preferences have been reported (11, 59) . Thus, it is not clear whether the different degradation patterns are due to slight conformational differences between mouse and human p53 that influence recognition by calpains or whether they are due to amino acid variations at the cleavage sites per se. It is important to note that the proteolytic cleavage of p53 by calpains is completely distinct from the proteolytic cleavage induced following interaction of p53 with damaged DNA (50) . In the latter case, the cleavage of p53 is observed in calcium-free conditions and also with purified p53, ruling out any involvement of calpains. Nonetheless, there are some similarities between the two cleavage products (of 40 and 35 kDa following interaction with damage DNA) and a conformationally intact central core domain, reactive with monoclonal antibody PAb246 (Fig. 3C and reference 50) . Since some functions of p53 are activated by amino and carboxy truncations, proteolytic cleavage may represent one mechanism regulating the numerous functions of p53.
Because they are sensitive to conformational motifs, calpains can be used as topological probes in protein structure studies. Very interestingly, the different mutants of p53 tested in our survey displayed very different sensitivities to these proteases. Some were as sensitive as the wild-type p53. However, some, such as R248W, R273C, and R273H, were more sensitive, while others, such as the human R175H, M237I, and R273P mutants showed a reduced sensitivity, and another category, which includes the mouse A135V and the human A138V mutants translated at 39ЊC, showed very low sensitivity. Our data thus support the notion that the different p53 mutants do not adopt a unique conformation but rather adopt a variety of conformations that cannot be discriminated by immunotyping using antibodies PAb240 and PAb1620. It is potentially interesting that the highly sensitive mutants were also more extensively degraded than the wild-type protein in the assay used (Fig. 7A) . Whether mutation-linked conformational changes create or expose new cleavage sites to calpains is, however, not clear, since (i) due to the complexity of the pattern of translation products in the case of the human protein, the analysis of degradation products is usually difficult, and (ii) using certain batches of S100 cell extract, we have sometimes observed rather extensive cleavage of wild-type p53 (e.g., Fig. 2 ). Using a different assay involving a recombinant protein, Bargonetti et al. (2) have shown that (i) p53 possesses multiple cleavage sites for thermolysin on either side of a protease-resistant central core domain of 27 kDa displaying DNA binding activity and (ii) in the presence of thermolysin, certain mutants, such as R248W and R273H, showed a proteolysis profile similar to that of the wild-type human protein, whereas the core domain was degraded in the case of the V143A and R175H mutants, presumably because of conformation changes induced by the mutations which render cryptic cleavage sites accessible to the protease. Taken with our own observations, this work shows that susceptibility to various proteases may be used for identifying novel variant conformations of mutant p53 that cannot be detected by classical immunotyping.
Contribution of calpains to p53 breakdown in vivo? The mechanisms responsible for wild-type and mutant p53 protein breakdown are poorly understood, and multiple catabolic pathways may exist. Moreover, the relative contributions of different pathways may vary according to the cellular context and/or the physiological conditions.
The ubiquitin-proteasome system is responsible for the destruction of numerous intracellular proteins (for reviews, see references 10, 22, 27, 29, and 61). Some evidence is consistent with a role for this system in the degradation of wild-type p53 in vivo, since p53 destruction has been shown to require energy (24) and an active E1 ubiquitin-activating enzyme, at least in mouse embryo fibroblasts (9) , and inhibition of the proteasome leads to stabilization of p53 and accumulation of ubiquitinated forms of p53 in human fibroblasts (38) . One indication that p53 can be degraded by different mechanisms in vivo is the fact that E6 proteins from human papillomavirus types 16 and 18 have been shown to accelerate p53 destruction and thereby to favor the development of tumors of the cervix (63) . In this case, degradation unambiguously involves tagging of p53 by multiubiquitin chains, due to a cellular protein called E6-AP that interacts with p53 only in the presence of E6 (10, 61, 62, 65) . However, whether this corresponds to acceleration of a physiological p53 ubiquitin-dependent degradation pathway or to a deviation toward a more efficient one is not yet clear. It must also be stressed that p53 may also constitute a heterogeneous population of molecules with respect to intracellular proteolytic systems. This is exemplified by the fact that DNAbound, but not free, p53 is resistant to E6-mediated degradation (50) . Interestingly, neither the presence of E6 nor that of oligonucleotides carrying the CON consensus p53 DNA binding site (20) facilitates or inhibits p53 proteolysis by calpains in our in vitro degradation assays (results not shown).
We have shown here that the inhibition of calpains in transient transfection experiments leads to a significant elevation of p53-dependent transcription in SAOS and H358a cells. Moreover, elevation of p53 abundance was observed in MCF7 cells transfected with a calpastatin expression vector, and calpain inhibitors allowed p53 accumulation in ts20 cells upon activation of calpains by calcium ionophore (Fig. 8) . Since p53 is a sensitive substrate for calpains in vitro, these observations raise the interesting possibility that calpains can also contribute to p53 breakdown in vivo and thus support the notion that p53 may not exclusively be degraded by the ubiquitin-proteasome pathway. We cannot, however, formally exclude the possibility that calpains regulate p53 steady-state levels by indirect mechanisms and/or modulate p53 transcriptional activity by interfering with intracellular signal transduction cascades. It is of note that the two types of regulation may not be mutually exclusive. If p53 is indeed degraded by calpains in vivo, the major issues will be (i) to determine the relative contribution of calpain-mediated destruction of p53 in respect to that of other intracellular proteolytic systems, such as the ubiquitinproteasome pathway, (ii) to characterize which proteolytic en-zymes reduce the calpain-generated peptides to amino acids, since neither we (this work and data not shown) nor Kubbutat and Vousden (33) could detect them in vivo, and (iii) to determine to what extent resistance to calpains can contribute to increased accumulation of mutant proteins in tumor cells. Concerning the last point, our results suggest that not all p53 mutants would be involved, since only a few of them showed resistance to proteolytic attack by calpains and some of them were even more sensitive. Along this line, it is worth emphasizing that not all p53 mutants are stabilized to the same extent, some mutants even remaining as unstable as the wild-type protein.
It may appear paradoxical that breakdown of a protein reputed to be nuclear might (in part) be achieved by a protease reputed to be exclusively cytoplasmic. It is, however, worth pointing out that (i) p53 has been reported to be cytoplasmic or partially cytoplasmic in various cell contexts, (ii) the transport of nuclear proteins into the nucleus does not always occur immediately after synthesis, (iii) although the possible presence of calpains in the nucleus is controversial, a minor fraction of ubiquitous calpains has been reported to be nuclear in established cell lines (35) , (iv) micro-but not millicalpain has been shown to be capable of entering the nucleus upon elevation of calcium concentration in digitonin-permeabilized A431 cells (43) , (v) several nuclear matrix proteins (42, 44) , as well as several transcription factors, have also been shown to be highly susceptible substrates for calpains in vitro (4, 5, 66, 72) , (vi) apparently, calpain-dependent degradation of p53 could be obtained in a nuclear fraction of MCF7 cells in vitro (33) , (vii) inhibition of calpains in vivo leads to higher c-Fos and c-Jun transcription factor activity in transient transfection assays (reference 29 and our unpublished observations), and (viii) during mitosis, the nuclear envelope gets disrupted, thus allowing interactions between nuclear and cytoplasmic proteins. Taken together, these observations support the notion that nuclear proteins can be substrates for ubiquitous calpains. However, whether proteolysis occurs mainly before (for controlling the abundance of proteins available for transport into the nucleus or the turnover of proteins with blocked nuclear transport, for example) and/or after transport of substrates into the nucleus will have to be elucidated.
